MedTrace Logo

A Test of Different Incentives and How Effectively They Motivate Walking Behaviour

NCT06395233 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-05-02

No results posted yet for this study

Summary

This study aims to test the effectiveness of different types of incentives to motivate walking among people who use a tracker app. App users will be randomly allocated to three groups, Group 1 will received assured incentives in the form of points per minute of walking, Group 2 will received non-assured incentives in the form of prize draw tickets, one ticket per minute of walking and Group 3 will receive a combination of the two.

App-users will be invited to join the study and those who consent to joining will track their walking activity for 12 weeks using the BetterPoints app. Participants will also be asked to complete a survey at the start and end of the study period to assess motivation and responsiveness to reward.

At the end of the 12 weeks intervention period, changes in minutes of walking from the start of the study to three follow up time points will be assessed and compared between groups. Total minutes of walking will also be compared between groups. Differences in reported levels of autonomous motivation will be assessed between the start and end of the study and between groups.

Conditions

  • Physical Inactivity

Interventions

DEVICE

BetterPoints App

The BetterPoints app is a smartphone application that uses incentives and gamification to motivate physical activity.

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Hannah McCarthy, MA · University College, London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-29
Primary Completion
2024-07-29
Completion
2024-07-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06395233 on ClinicalTrials.gov